Scientists track heart changes after attack to predict failure risk
NCT ID NCT02047396
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 1,599 people who had a first heart attack to see how their hearts remodel over time. Researchers want to link these changes to later heart failure. Participants are from several Minnesota counties and will be monitored for heart failure and death. No new drug or treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict who will develop heart failure after a heart attack, leading to better monitoring or early treatment.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly improve patient outcomes, and results may not apply to people outside the specific communities studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,599 people
The number who actually took part.
- Started
-
Jan 2014
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects in the 7 County area who are admitted to the Mayo Clinic Hospitals in Rochester, Minnesota who have their first myocardial infarction and are willing to have blood drawn and return for an echocardiogram in 3 months.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Hospitalized patients with a clinical diagnosis of Myocardial Infarction. 2. Residents of Olmsted, Dodge, Goodhue, Wabasha, Winona, Fillmore and Mower Counties. 3. Able to provide informed consent. Exclusion Criteria: 1. Previous clinical diagnosis of Myocardial Infarction 2. Previous diagnosis of Heart Failure and/or Cardiomyopathy 3. Diagnosis of Apical Ballooning Syndrome 4. Planned Coronary Artery Bypass Graft (CABG) during index hospitalization 5. Unable to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?